VC  RiverVest Venture Partners

http://www.rivervest.com





     Office Locations:

101 S. Hanley Road
Suite 1850
St. Louis, MO 63105
Phone: 314-726-6700
Fax: 314-726-6715

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Expansion
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in September 2000, RiverVest Venture Partners has focused exclusively on innovations in life sciences. The firm identifies, found, and actively incubate promising life sciences companies, particularly in the medical device and biopharmaceutical industries. RiverVest provides practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward. RiverVest also invests in select later-stage life science companies to diversify risk and maximize portfolio returns. Since its inception, RiverVest has raised two investment funds with total committed capital of $164 million, and supported more than 25 innovated life science companies.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Andrew B. Craig Special Limited Partner
    Jay W. Schmelter Managing Director
    John McKearn PhD Manging Director
    Karen Spilizewski Vice President
    Marilyn J. Slavich Controller

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/16/2017


      VentureMed


      OH


      $15,000,000


      Series B


      08/02/2017


      Amplyx Pharmaceuticals


      CA


      $67,000,000


      Series C


     

    Portfolio companies include:


      Accumetrics
        web link


      Allakos
        web link


      Amplyx Pharmaceuticals
        web link


      Cabrellis Pharmaceuticals


      Calypso Medical Technologies
        web link


      Cameron Health
        web link


      Centerre Healthcare
        web link


      CGI Pharmaceuticals
        web link


      Conforma Therapeutics
        web link


      Cydex
        web link


      Excaliard Pharmaceuticals
        web link


      Genoa Pharmaceuticals
        web link


      Idev Technologies
        web link


      Kaperio
        web link


      Kereos
        web link


      Lumena Pharmaceuticals
        web link


      Luminous Medical
        web link


      Lutonix
        web link


      Lyric Pharmaceuticals
        web link


      MacroGenics
        web link


      Mpex Pharmaceuticals
        web link


      Neuros Medical
        web link


      Otonomy
        web link


      Salient Surgical Technologies
        web link


      Securus Medical Group


      Tioma Therapeutics
        web link


      Tryton Medical
        web link


      Velocimed
        web link


      VentureMed
        web link


      Xoft
        web link


      ZS Pharma
        web link


     

    Recent News: